(Q71844241)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600567%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600567%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600567%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

L Cheung

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600567%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J L Murray

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600567%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

M G Rosenblum

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600567%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 May 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600567%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600567%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600567%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600567%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

339-345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600567%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01519635

21 October 2019

exact match

0 references

cites work

Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer

1 reference

12 December 2020

Clinical radioimmunodetection of cancer with radioactive antibodies to human chorionic gonadotropin

1 reference

12 December 2020

Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein

1 reference

12 December 2020

Immunotoxins containing single-chain ribosome-inactivating proteins.

1 reference

12 December 2020

Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A

1 reference

12 December 2020

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

1 reference

12 December 2020

New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo.

1 reference

12 December 2020

In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. IV. Cytotoxic effect of an anti-T11-gelonin immunotoxin

1 reference

12 December 2020

Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies

1 reference

12 December 2020

Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.

1 reference

12 December 2020

Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody

1 reference

12 December 2020

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma

1 reference

12 December 2020

Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates

1 reference

12 December 2020

1 reference

12 December 2020

Imaging of melanoma with L-131-labeled monoclonal antibodies

1 reference

12 December 2020

Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins

1 reference

12 December 2020

Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin

1 reference

12 December 2020

A highly cytotoxic human transferrin-ricin A chain conjugate used to select receptor-modified cells.

1 reference

12 December 2020

Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells.

1 reference

12 December 2020

Redesigning nature's poisons to create anti-tumor reagents

1 reference

12 December 2020

Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation

1 reference

12 December 2020

A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin gelonin.

1 reference

12 December 2020

Immunotoxins: A New Approach to Cancer Therapy

1 reference

12 December 2020

Effect of linkage variation on pharmacokinetics of ricin A chain-antibody conjugates in normal rats

1 reference

12 December 2020

Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancer

1 reference

12 December 2020

An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors

1 reference

12 December 2020

Characterization of immunotoxins active against ovarian cancer cell lines

1 reference

12 December 2020

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01519635

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600567%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference